This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company’s leading anti-cancer agent, Rexin-G. Administered clinically by simple intravenous infusion,
Mr Emerson was most recently president and CEO of American Medical Systems. He will be replacing Chen Barir, who will continue to serve on the Galil Medical board
However, the analysis of the unblinded primary endpoint data did not show the required level of statistical significance when comparing the SinuNase arm to the control arm. The
Lucid’s VivaScope reflective confocal microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin
Sam Owusu-Akyaw, president and CEO of Osteotech, said: “The ‘146 patent is an important part of our strategic vision providing patent protection for certain of our current Grafton
The safety data from this interim analysis suggest that the drug was well-tolerated with no serious adverse events reported in heart failure patients exposed to the intended range
LDR began enrolling patients in the first concurrent one and two-level cervical artificial disc study in April of 2006, following nearly two years of clinical experience outside the
The therapeutic areas included in these awards are infectious diseases, immunology/vaccines, cardiovascular diseases, dermatology, and metabolic disorders. Services to be provided include project management, field monitoring, medical monitoring/writing,
The clinical trial was a randomized, open label, cross-over study evaluating the pharmacokinetic profile of two doses of unit dose budesonide (UDB) given twice daily in 32 adults
Under this agreement, Cantel Medical, through its Saf-T-Pak and Crosstex business units, will manufacture National Safety Council (NSC) or Saf-T-Pak co-branded Flu Defense Kits and other product configurations
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.